title: Effectiveness of postprandial Humalog in toddlers with diabetes.
abstract: OBJECTIVE
  The purpose of this study was to determine whether postprandial administration of the new rapid-acting insulin analog Humalog could effectively reduce glucose excursions in children <5 years old.
  
  
  METHODS
  Human Regular insulin given before a meal was compared with the same dose of Humalog after a meal of equal carbohydrate content in five toddlers with insulin-dependent (type 1) diabetes mellitus. In addition, the use of Humalog before a meal was compared with Humalog given after a meal of equal carbohydrate content in five other toddlers. The dose of long-acting insulin was not changed during the study period. Blood glucose levels were determined at fasting and at 1, 2, and 4 hours postprandially.
  
  
  RESULTS
  The 2-hour glucose excursions were significantly lower when postprandial Humalog administration was compared with preprandial Human Regular insulin administration. In contrast, glucose excursions were similar when Humalog was taken before or after the meal.
  
  
  CONCLUSIONS
  These data show that it is efficacious to give Humalog insulin postprandially in toddlers with type 1 diabetes, allowing increased safety for the young child. The insulin dose can be both matched to the actual food intake and timed to give families increased flexibility and control at mealtime.
authors.affiliation: Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA.
authors.forename: K S
authors.initials: KS
authors.lastname: Rutledge
authors.forename: H P
authors.initials: HP
authors.lastname: Chase
authors.forename: G J
authors.initials: GJ
authors.lastname: Klingensmith
authors.forename: P A
authors.initials: PA
authors.lastname: Walravens
authors.forename: R H
authors.initials: RH
authors.lastname: Slover
authors.forename: S K
authors.initials: SK
authors.lastname: Garg
mesh_terms: D001786:Blood Glucose / Q000187:drug effects; D002675:Child, Preschool; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007223:Infant; D007328:Insulin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D061268:Insulin Lispro; D019518:Postprandial Period
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D061268:Insulin Lispro